The effect of insulin glargine on glycemic control, morbidity, and length of stay in hospitalized subjects with diabetes receiving enteral nutrition

Trial Profile

The effect of insulin glargine on glycemic control, morbidity, and length of stay in hospitalized subjects with diabetes receiving enteral nutrition

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2009

At a glance

  • Drugs Insulin; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Dec 2007 Status changed from in progress to completed.
    • 14 Sep 2006 Status change
    • 04 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top